• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

A Roadmap on the Prevention of Cardiovascular Disease Among People Living With Diabetes.

作者信息

Mitchell Sharon, Malanda Belma, Damasceno Albertino, Eckel Robert H, Gaita Dan, Kotseva Kornelia, Januzzi James L, Mensah George, Plutzky Jorge, Prystupiuk Maksym, Ryden Lars, Thierer Jorge, Virani Salim S, Sperling Laurence

机构信息

World Heart Federation, Geneva, Switzerland.

International Diabetes Federation, Brussels, Belgium.

出版信息

Glob Heart. 2019 Sep;14(3):215-240. doi: 10.1016/j.gheart.2019.07.009.

DOI:10.1016/j.gheart.2019.07.009
PMID:31451236
Abstract
摘要

相似文献

1
A Roadmap on the Prevention of Cardiovascular Disease Among People Living With Diabetes.糖尿病患者心血管疾病预防路线图
Glob Heart. 2019 Sep;14(3):215-240. doi: 10.1016/j.gheart.2019.07.009.
2
2013 ESC/EASD guidelines on the management of diabetes and cardiovascular disease: established knowledge and evidence gaps.2013年欧洲心脏病学会/欧洲糖尿病研究学会糖尿病与心血管疾病管理指南：既有知识与证据空白
Diab Vasc Dis Res. 2014 Jan;11(1):5-10. doi: 10.1177/1479164113512859. Epub 2013 Nov 19.
3
[Diabetes and coronary heart disease frequently appear together. New guidelines regulate therapy and prevention].糖尿病和冠心病经常同时出现。新指南规范了治疗与预防措施。
MMW Fortschr Med. 2006 Oct 12;148(41):10-1.
4
Cardiovascular prevention in patients with diabetes and prediabetes.糖尿病和糖尿病前期患者的心血管疾病预防
Herz. 2008 Apr;33(3):170-7. doi: 10.1007/s00059-008-3105-5.
5
Economics of type 2 diabetes prevention.2型糖尿病预防的经济学
Przegl Lek. 2006;63 Suppl 4:9-11.
6
Widespread statin use recommended for patients with type 2 diabetes.建议2型糖尿病患者广泛使用他汀类药物。
JAMA. 2004 May 26;291(20):2419-20. doi: 10.1001/jama.291.20.2419.
7
Updated risk factors should be used to predict development of diabetes.应使用更新后的风险因素来预测糖尿病的发生。
J Diabetes Complications. 2017 May;31(5):859-863. doi: 10.1016/j.jdiacomp.2017.02.012. Epub 2017 Mar 2.
8
Clinical trials and clinical practice--bridging the gaps in type 2 diabetes. An evidence-based approach to risk factor modification in type 2 diabetes.临床试验与临床实践——弥合2型糖尿病的差距。一种基于证据的2型糖尿病危险因素修正方法。
Aust N Z J Med. 2000 Aug;30(4):483-91. doi: 10.1111/j.1445-5994.2000.tb02056.x.
9
Diabetes and cardiovascular disease.糖尿病与心血管疾病。
Diabetes Obes Metab. 2003 Nov;5 Suppl 1:S11-8. doi: 10.1046/j.1462-8902.2003.0311.x.
10
Aspirin for primary prevention of cardiovascular events in people with diabetes.阿司匹林用于糖尿病患者心血管事件的一级预防。
J Am Coll Cardiol. 2010 Jun 22;55(25):2878-86. doi: 10.1016/j.jacc.2010.04.003.

引用本文的文献

1
Barriers in prescribing antidiabetic medications with cardiovascular benefits: practice, experience, and attitudes of GPs in Croatia.开具具有心血管益处的抗糖尿病药物的障碍：克罗地亚全科医生的实践、经验和态度
BMC Prim Care. 2025 May 2;26(1):143. doi: 10.1186/s12875-025-02837-7.
2
Trends in In-Hospital Mortality in Patients Admitted With Cardiovascular Diseases in the United States With Demographics and Risk Factors of All Cardiovascular In-Hospital Mortality: Analysis of the 2021 National Inpatient Sample Database.美国心血管疾病住院患者的院内死亡率趋势以及所有心血管疾病院内死亡的人口统计学和风险因素：对2021年全国住院患者样本数据库的分析
Cureus. 2024 Oct 1;16(10):e70620. doi: 10.7759/cureus.70620. eCollection 2024 Oct.
3
The Reasons for the Low Uptake of New Antidiabetic Drugs with Cardiovascular Effects-A Family Doctor Perspective.
具有心血管效应的新型抗糖尿病药物使用率低的原因——家庭医生视角
J Clin Med. 2024 Mar 12;13(6):1617. doi: 10.3390/jcm13061617.
4
Effects of a comprehensive structured patient education intervention on disease-related knowledge and behaviour change among people living with type 2 diabetes in the Philippines.一项综合性结构化患者教育干预措施对菲律宾2型糖尿病患者疾病相关知识及行为改变的影响。
Front Rehabil Sci. 2024 Feb 28;5:1374850. doi: 10.3389/fresc.2024.1374850. eCollection 2024.
5
World Heart Federation Roadmap for Secondary Prevention of Cardiovascular Disease: 2023 Update.世界心脏联盟心血管疾病二级预防路线图：2023年更新版
Glob Heart. 2024 Jan 22;19(1):8. doi: 10.5334/gh.1278. eCollection 2024.
6
Peer Support in the Management of Diabetes to Improve Cardiovascular Disease Outcomes in Low- and Middle-Income Countries (LMICs).同伴支持在糖尿病管理中以改善中低收入国家（LMICs）的心血管疾病结局。
Glob Heart. 2023 Sep 15;18(1):48. doi: 10.5334/gh.1263. eCollection 2023.
7
A Call to Action to Address the Burden of Cardiovascular Disease in People with Diabetes.呼吁行动起来，解决糖尿病患者的心血管疾病负担。
Glob Heart. 2022 Dec 19;17(1):87. doi: 10.5334/gh.1176. eCollection 2022.
8
Clinical significance of neutrophil gelatinase-associated lipocalin and sdLDL-C for coronary artery disease in patients with type 2 diabetes mellitus aged ≥ 65 years.中性粒细胞明胶酶相关脂质运载蛋白和小而密低密度脂蛋白胆固醇对年龄≥65 岁 2 型糖尿病患者冠状动脉疾病的临床意义。
Cardiovasc Diabetol. 2022 Nov 17;21(1):252. doi: 10.1186/s12933-022-01668-5.
9
World Heart Federation Roadmap for Digital Health in Cardiology.世界心脏联合会心脏病学数字健康路线图。
Glob Heart. 2022 Aug 26;17(1):61. doi: 10.5334/gh.1141. eCollection 2022.
10
Serum Tenascin-C and Alarin Levels Are Associated with Cardiovascular Diseases in Type 2 Diabetes Mellitus.血清腱生蛋白-C和阿拉林水平与2型糖尿病患者的心血管疾病相关。
Int J Endocrinol. 2022 Apr 21;2022:2009724. doi: 10.1155/2022/2009724. eCollection 2022.